PM
BTAI icon

Prosight Management’s BioXcel Therapeutics BTAI Stock Holding History

Prosight Management’s Portfolio BTAI Stock Details BTAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,863
Closed -$1.29M – 38
2020
Q3 		$1.29M Buy
+1,863
New +$1.29M 0.61% 35